Affymetrix, InterMune slide in early action By: MarketWatch April 28, 2011 at 11:24 AM EDT Meanwhile, shares of Bristol-Myers Squibb edge up after the pharmaceutical company reported a better-than-expected first-quarter profit. Read More >> Related Stocks: Bristol-Myers Squibb Macy's Merck & Co Vertex Pharmaceuticals